- Medical Devices
- Friday, 23 Aug 2019
Gastric Balloon Market to double up by 2027 US$ 152.1 Mn
The gastric balloon is a niche market in nature with limited number of players, having considerable revenue in the market. Most of the companies operating in the gastric balloon market are offering their products in the European and the Middle East region, whereas, only three products have FDA approvals for the commercialization of their products.
The most notable market participants are Apollo Endosurgery, Inc. and Allurion Technologies, Inc., ENDALIS, Helioscopie Medical Implants, LEXEL SRL, MEDSIL, Obalon Therapeutics, Inc., ReShape Lifesciences, Inc., Silimed, and Spatz FGIA, Inc. occupying a considerable share of the market owing to their offerings to the market.
Market leaders are involved in activities such as, obtaining approvals to serve a better customer base. For instance, In December, 2018, Obalon received FDA approval of the Obalon Navigation System, which eliminates the need to use x-ray when placing the Obalon Balloon System. The Obalon Navigation System and Touch Inflation Dispenser are expected to be commercially available during the first quarter of 2019 in the United States. Also, during February, 2018, Apollo received approval from the South Korean Ministry of Food and Drug Safety’s (MFDS) for the ORBERA Intragastric Balloon System. Shin Han Systek Co. Ltd. was declared as the exclusive distributor for ORBERA in South Korea. Owing to these approvals, it has been possible for the companies to serve larger customer base as well as provide better weight loss solutions to the patients.
The global gastric balloon market is expected to reach US$ 152.1 Mn in 2027 from US$ 67.3 Mn in 2018. The gastric balloon market is estimated to grow with a CAGR of 9.7% from 2019-2027.
Along with obtaining approvals, various companies have signed agreements in order to strengthen as well as extend its customer base. Additionally various companies are also undergoing other strategic alliances such as collaboration partnerships to garner their significance and remain competitive in the market.
Related Industry Updates
Analyzing Impacts Of COVID-19 On Healthcare Analytical Testing Services Market Effects, Aftermath And Forecast To 2028
May 11, 2021
Sternal Closure Systems Market is expected to reach US$ 5.74 billion by 2030
Feb 08, 2024
EchoNous, Inc. Announces FDA Approval for Its New KOSMOS Platform
Mar 27, 2020
SimplyRFiD Automates Eyewear Inventory for Eye Docs
May 25, 2020
Plasma Fractionation Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product ( Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Products ); Application ( Neurology, Immunology, Hematology, Critical Care, Pulmonology and Other Applications ); End User ( Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes and Oth
Apr 19, 2021
How Coronavirus Pandemic Will Impact Asia Pacific Antibiotics Market? Industry Trends and Developments 2020-2027
Dec 17, 2020
OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET
Nov 06, 2019